Tirzepatide
Research Compound
$62
| Pack size | 1 vial, size selected above |
| Also known as | LY3298176 |
| Compound type | Lipidated peptide; dual GIP / GLP-1 receptor agonist |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.5 g/mol |
| CAS number | 2023788-19-2 |
| Form | Lyophilized powder |
| Purity | 99% Pure |
| Storage | Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol. |
| Intended use | Laboratory research only |
This product is sold exclusively for laboratory research use by qualified professionals and institutions. It is not a drug, food, cosmetic, or dietary supplement, and is not approved for use in humans or animals. Handling must be performed only by trained personnel in a controlled research setting.
Research overview
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor, with greater affinity for GIP receptors. This dual-incretin activity makes it a reference compound for comparing combined GIP/GLP-1 signaling with selective GLP-1 agonism in receptor pharmacology research.
Research areas
- Incretin receptor pharmacology (GIP and GLP-1)
- Dual-agonist peptide design
Sources
Handling and storage
Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol.